Results 21 to 30 of about 11,560 (188)
Clinical value of nitric oxide parameters in children with bronchial asthma [PDF]
Exhaled nitric oxide (eNO), as a marker of eosinophilic inflammation in the airway, has been widely utilized in the diagnosis and treatment of asthma. The fractional concentration of exhaled NO (FeNO) mainly reflects the degree of airway inflammation. By
Wei Ziqian, Yilimuguli Abudukeremu, Wu Baojing
doaj +1 more source
How to use the fractional exhaled nitric oxide test [PDF]
Measurement of fractional exhaled nitric oxide (FeNO) has become a mainstream, NICE-recommended, objective test of asthma severity. We explore the uses and practical issues with the FeNO test using clinically relevant questions for general paediatricians.
Rhiannon Hoggins +3 more
openaire +2 more sources
bronchial asthma is a chronic condition that is considerably prevalent among children. According to scientific evidence, cat allergens are most frequently responsible for the onset of asthma manifestations in children. Children are more likely to develop
Mariia Kryvopustovа
doaj +1 more source
Cost utility of fractional exhaled nitric oxide monitoring for the management of children asthma
Introduction Fractional exhaled nitric oxide is a simple, non-invasive measurement of airway inflammation with minimal discomfort to the patient and with results available within a few minutes.
Jefferson Antonio Buendía +2 more
doaj +1 more source
INTRODUCTION: Fractional exhaled nitric oxide (FENO) is a measurement of fractional nitric oxide (NO) concentration in exhaled breath. It is a quantitative, noninvasive, simple, and safe method to measure airway inflammation for the assessment of airways
V Lakshmi +4 more
doaj +1 more source
Fractional exhaled nitric oxide (FeNO) has gained great clinical importance as a biomarker of type 2 inflammation in chronic airway diseases such as asthma.
J. M. Escamilla-Gil +2 more
semanticscholar +1 more source
Background: The fractional exhaled nitric oxide (FENO) test is a point-of-care test that is used in the assessment of asthma. Objective: To provide evidence-based clinical guidance on whether FENO testing is indicated to optimize asthma treatment in ...
S. Khatri +20 more
semanticscholar +1 more source
Fractional exhaled nitric oxide in asthma: an update [PDF]
ABSTRACTIn asthma, clinical symptoms and lung function are insensitive in reflecting the underlying airway inflammation, and monitoring of this process has only recently become available. Fractional exhaled nitric oxide (FeNO) is now recognized as a reliable surrogate marker of eosinophilic airway inflammation and offers the advantage of being ...
Alessandra, Sandrini +3 more
openaire +2 more sources
Background: Fractional exhaled nitric oxide (FeNO) is a biomarker of airway inflammation associated with airway hyper-responsiveness and type-2 inflammation.
T. Pianigiani +10 more
semanticscholar +1 more source
Background and objective: In patients with asthma, fractional exhaled nitric oxide (FeNO) is a biomarker for eosinophilic airway inflammation. However, the correlation with the blood eosinophil count, immunoglobulin E (IgE), and spirometric values is not
M. Al Ghobain +6 more
semanticscholar +1 more source

